• A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome
• A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer
• A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency
• A Nutrigenomic View on the Premature-Aging Disease Fanconi Anemia
• A patient with axial spondylarthritis who experienced pancytopenia while receiving anti-TNF therapy
• A Rare Case of Hemolysis Following Antithymocyte Globulin in a Pediatric Patient With Aplastic Anemia Receiving Immunosuppressive Therapy
• Aberrant baseline cytokine profile in patients with newly diagnosed acquired aplastic anaemia correlates with disease severity and the treatment response
• ABO incompatibility haploidentical peripheral blood stem cell transplantation combined with a single cord blood unit for severe aplastic anemia patients
• Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE : Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia
• Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE: Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia
• Advanced Analysis and Validation of a microRNA Signature for Fanconi Anemia
• ALDH2 mutations and defense against genotoxic aldehydes in cancer and inherited bone marrow failure syndromes
• Alemtuzumab-based conditioning regimen before hematopoietic stem cell transplantation in patients with short telomere syndromes: a retrospective study of the SFGM-TC
• Allogeneic hematopoietic cell transplant for bone marrow failure or myelodysplastic syndrome in dyskeratosis congenita/telomere biology disorders: Single-center single-arm open-label trial of reduced intensity conditioning without radiation
• Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation
• Allogeneic Hematopoietic Stem Cell Transplantation-Induced Anaphylaxis in 2 Pediatric Cases
• Allogeneic stem cell transplantation for inherited metabolic disorders: 35 years' experience at a single institution
• Alternative donors in severe aplastic anemia
• Analyzing the role of ferroptosis in ribosome-related bone marrow failure disorders: From pathophysiology to potential pharmacological exploitation
• Aplastic anemia
• Arthroscopic Management of Complex Knee Pathologies in a 45-Year-Old Male: A Case Report
• Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag
• Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1
• Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
• Case report: Ghosal hematodiaphyseal dysplasia-A rare cause of skeletal dysplasia and cytopenia
• Causal role of immune cells in aplastic anemia: Mendelian randomization (MR) study
• Causes and characteristics of pre-engraftment mortality after allogeneic hematopoietic stem cell transplantation
• CCAR1 promotes DNA repair via alternative splicing
• Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis
• Clinical analysis on the impact of pretransplant iron overload on allogeneic hematopoietic stem cell transplantation for patients with acquired severe aplastic anemia in pediatric
• Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report
• Clinical Observation on Haploid Hematopoietic Stem Cells Combined with Umbilical Cord Blood Double Transplantation for Aplastic Anaemia in Children
• Clinical relevance of SCN and CyN induced by ELANE mutations: a systematic review
• Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19
• Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study
• Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore
• Current trends in the treatment of aplastic anemia
• Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acq
• De Novo Deep Intron ELANE Mutation Resulting in Severe Congenital Neutropenia
• Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis
• Decreased spermatogonial numbers in boys with severe haematological diseases
• Deficiency of Adenosine Deaminase 2
• Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients
• Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)
• Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study
• Dyskeratosis congenita associated with a novel missense variant in TERT: Approach for the dermatologists
• Effectiveness of exercise rehabilitation on aplastic anemia patients receiving hematopoietic stem cell transplantation: study protocol for a randomized controlled trial
• Emerging genetic technologies informing personalized medicine in SDS and other inherited bone marrow failure disorders
• Encephalitozoon hellem infection after haploidentical allogeneic hematopoietic stem cell transplantation in children: a case report
• Exploring the mechanism by which <em>Angelica sinensis</em> improves haematopoietic function in aplastic anaemia
• Expression of <em>MiR-144/451</em> in Different Types of Anemia
• Fanconi Anaemia associated with café au lait spots: A rare case report
• Fanconi Anemia Complicated by Cervical Precancer, Vulvar, and Oral Squamous Cell Cancer
• Fanconi Anemia in a 31-Year-Old Patient with Multiple Malignant Tumor Foci, Including Appendiceal Cancer, and Multiple Coexisting Pathologies
• GATA2 heterozygosity causes an epigenetic feedback mechanism resulting in myeloid and erythroid dysplasia
• Generation of iPSC lines and isogenic gene-corrected lines from two individuals with RPS19-mutated Diamond-Blackfan anemia syndrome
• Germline variants in acquired aplastic anemia: current knowledge and future perspectives
• Global microRNA profiling of bone marrow-MSC derived extracellular vesicles identifies miRNAs associated with hematopoietic dysfunction in aplastic anemia
• Hemophagocytic Lymphohistiocytosis Gene Variants in Severe Aplastic Anemia and Their Impact on Hematopoietic Cell Transplantation Outcomes
• Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma
• HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt
• Homing and characteristic analysis of macrophage in immune-mediated aplastic anemia model mice
• Homozygous Variant of <em>FANCM</em> of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism
• Hypotonia and Poor Weight Gain in a 4-month-old Girl
• Inhibition of caspase-8 cascade restrains the osteoclastogenic fate of bone marrow cells
• International Society for Cell &amp; Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced
• Management of Mucormycosis Caused by Rhizopus arrhizus in a Child with Severe Aplastic Anemia and Diabetes Mellitus Undergoing Transplantation
• Molecular pathophysiology of germline mutations in acute myeloid leukemia
• Myeloid-derived growth factor in diseases: structure, function and mechanisms
• Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia
• Oral health management in children with severe congenital neutropenia with periodontitis: Case report
• Oral health-related quality of life in Fanconi anemia: a cross-sectional study
• Overexpression of human SAMD9 inhibits protein translation and alters MYC signaling resulting in cell cycle arrest
• Performance of Tumor Surveillance for Children With Cancer Predisposition
• Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes
• Phenotypic Variability and Cutaneous Features in 2 Siblings with Fanconi Anaemia and FANCA Mutation
• Radiological Features of Extramedullary Hematopoiesis in a Young Male With Beta-Thalassemia: A Case Report
• Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience
• Reduced anti-Mullerian hormone levels in males with inherited bone marrow failure syndromes
• Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia
• Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a <em>STAT1</em>-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background
• Role of metabolites in mediating the effect of triacylglycerol on aplastic anemia
• Role of Telomere in Clonal Evolution of Acquired Aplastic Anemia--Review
• SBDS Gene Mutation Increases ROS Production and Causes DNA Damage as Well as Oxidation of Mitochondrial Membranes in the Murine Myeloid Cell Line 32Dcl3
• Splicing regulation of DNA repair via CCAR1
• Successful living-donor liver transplantation for neonatal hemochromatosis due to transient abnormal myelopoiesis with Down syndrome: Case report and review of the literature
• The Compromised Fanconi Anemia Pathway in Prelamin A-Expressing Cells Contributes to Replication Stress-Induced Genomic Instability
• The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
• The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients
• The Efficacy and Influencing Factors of Cyclosporine Alone in the Treatment of Children with Acquired Aplastic Anemia
• The Fanconi anemia core complex promotes CtIP-dependent end resection to drive homologous recombination at DNA double-strand breaks
• The relation between interleukin-6 and interleukin-8 serum levels and the severity of acquired aplastic anemia in adult patients: A single center study
• The role of registries in hematological disorders
• The role of SLFN11 in DNA replication stress response and its implications for the Fanconi anemia pathway
• The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway
• Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches
• Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis
• Towards a Cure for Diamond-Blackfan Anemia: Views on Gene Therapy
• Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report
• Why do children not survive extracorporeal membrane oxygenation?